Hypoactive sexual desire disorder: Difference between revisions
From WikiMD's Wellness Encyclopedia
No edit summary Tag: Manual revert |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Hypoactive Sexual Desire Disorder | |||
| synonyms = HSDD | |||
| field = [[Psychiatry]], [[Sexual medicine]] | |||
| symptoms = Low sexual desire, lack of sexual thoughts or fantasies | |||
| onset = Can occur at any age | |||
| duration = Persistent or recurrent | |||
| causes = Multifactorial, including biological, psychological, and social factors | |||
| risks = Relationship issues, stress, hormonal changes | |||
| diagnosis = Clinical assessment, DSM-5 criteria | |||
| differential = [[Depression]], [[Anxiety disorders]], [[Hypogonadism]] | |||
| treatment = [[Psychotherapy]], [[Sex therapy]], [[Hormone therapy]], [[Flibanserin]] | |||
| medication = [[Flibanserin]], [[Bremelanotide]] | |||
| frequency = Common, varies by population | |||
}} | |||
Hypoactive Sexual Desire Disorder (HSDD) is a clinical condition characterized by a persistent or recurrent lack of sexual fantasies or desire for sexual activity. This condition is considered a sexual dysfunction and can cause significant distress or interpersonal difficulties for the individual affected. | Hypoactive Sexual Desire Disorder (HSDD) is a clinical condition characterized by a persistent or recurrent lack of sexual fantasies or desire for sexual activity. This condition is considered a sexual dysfunction and can cause significant distress or interpersonal difficulties for the individual affected. | ||
==Definition and Diagnosis== | ==Definition and Diagnosis== | ||
*HSDD is defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulties. Furthermore, the condition cannot be better explained by a non-sexual mental disorder, a consequence of severe relationship distress or other significant stressors, or attributable to the effects of a substance/medication or another medical condition<sup>[1]</sup>. | *HSDD is defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulties. Furthermore, the condition cannot be better explained by a non-sexual mental disorder, a consequence of severe relationship distress or other significant stressors, or attributable to the effects of a substance/medication or another medical condition<sup>[1]</sup>. | ||
*Diagnosis is typically made by a healthcare professional after a thorough medical and psychological examination, along with detailed inquiries about the individual's sexual and psychosocial history. | *Diagnosis is typically made by a healthcare professional after a thorough medical and psychological examination, along with detailed inquiries about the individual's sexual and psychosocial history. | ||
==Causes and Risk Factors== | ==Causes and Risk Factors== | ||
*There are various potential causes and risk factors for HSDD, including both physical and psychological issues: | *There are various potential causes and risk factors for HSDD, including both physical and psychological issues: | ||
| Line 15: | Line 29: | ||
*Medical treatment may include hormone therapy or FDA-approved medications like flibanserin for premenopausal women. | *Medical treatment may include hormone therapy or FDA-approved medications like flibanserin for premenopausal women. | ||
*Psychotherapy, such as cognitive-behavioral therapy (CBT), can be helpful in addressing underlying psychological issues or improving sexual communication with the partner<sup>[3] | *Psychotherapy, such as cognitive-behavioral therapy (CBT), can be helpful in addressing underlying psychological issues or improving sexual communication with the partner<sup>[3] | ||
==Epidemiology== | ==Epidemiology== | ||
HSDD is a relatively common condition, with studies suggesting that it affects approximately 10% of adult women and is less prevalent among men. The prevalence increases with age and other risk factors<sup>[4]</sup>. | HSDD is a relatively common condition, with studies suggesting that it affects approximately 10% of adult women and is less prevalent among men. The prevalence increases with age and other risk factors<sup>[4]</sup>. | ||
==Impact on Quality of Life== | ==Impact on Quality of Life== | ||
HSDD can have a significant impact on an individual's quality of life, affecting self-esteem, body image, and intimate relationships. The distress caused by this condition extends beyond the sexual realm, influencing overall mental health and well-being<sup>[5]</sup>. | HSDD can have a significant impact on an individual's quality of life, affecting self-esteem, body image, and intimate relationships. The distress caused by this condition extends beyond the sexual realm, influencing overall mental health and well-being<sup>[5]</sup>. | ||
==See also== | ==See also== | ||
* [[Sexual dysfunction]] | * [[Sexual dysfunction]] | ||
| Line 27: | Line 38: | ||
* [[Cognitive behavioral therapy]] | * [[Cognitive behavioral therapy]] | ||
* [[Diagnostic and Statistical Manual of Mental Disorders]] | * [[Diagnostic and Statistical Manual of Mental Disorders]] | ||
==References== | ==References== | ||
<references> | <references> | ||
*|American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: Author. | *|American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: Author. | ||
*|Basson, R. (2010). Women's sexual function and dysfunction: current uncertainties, future directions. International Journal of Impotence Research, 22(5), | *|Basson, R. (2010). Women's sexual function and dysfunction: current uncertainties, future directions. International Journal of Impotence Research, 22(5), 266–275. | ||
*|Clayton, A.H., Goldfischer, E.R., Goldstein, I., Derogatis, L., Lewis-D'Agostino, D.J., & Pyke, R. (2013). Validation of the Decreased Sexual Desire Screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). The Journal of Sexual Medicine, 6(3), | *|Clayton, A.H., Goldfischer, E.R., Goldstein, I., Derogatis, L., Lewis-D'Agostino, D.J., & Pyke, R. (2013). Validation of the Decreased Sexual Desire Screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). The Journal of Sexual Medicine, 6(3), 730–738. | ||
*|Shifren, J.L., Monz, B.U., Russo, P.A., Segreti, A., & Johannes, C.B. (2008). Sexual problems and distress in United States women: prevalence and correlates. Obstetrics & Gynecology, 112(5), | *|Shifren, J.L., Monz, B.U., Russo, P.A., Segreti, A., & Johannes, C.B. (2008). Sexual problems and distress in United States women: prevalence and correlates. Obstetrics & Gynecology, 112(5), 970–978. | ||
*|Derogatis, L., Clayton, A., Lewis- | *|Derogatis, L., Clayton, A., Lewis-D’Agostino, D., Wunderlich, G., & Fu, Y. (2008). Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with hypoactive sexual desire disorder. The Journal of Sexual Medicine, 5(2), 357–364. | ||
</references> | </references> | ||
* [[Category:Sexual and gender identity disorders]] | * [[Category:Sexual and gender identity disorders]] | ||
Latest revision as of 23:12, 3 April 2025
| Hypoactive Sexual Desire Disorder | |
|---|---|
| Synonyms | HSDD |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Low sexual desire, lack of sexual thoughts or fantasies |
| Complications | N/A |
| Onset | Can occur at any age |
| Duration | Persistent or recurrent |
| Types | N/A |
| Causes | Multifactorial, including biological, psychological, and social factors |
| Risks | Relationship issues, stress, hormonal changes |
| Diagnosis | Clinical assessment, DSM-5 criteria |
| Differential diagnosis | Depression, Anxiety disorders, Hypogonadism |
| Prevention | N/A |
| Treatment | Psychotherapy, Sex therapy, Hormone therapy, Flibanserin |
| Medication | Flibanserin, Bremelanotide |
| Prognosis | N/A |
| Frequency | Common, varies by population |
| Deaths | N/A |
Hypoactive Sexual Desire Disorder (HSDD) is a clinical condition characterized by a persistent or recurrent lack of sexual fantasies or desire for sexual activity. This condition is considered a sexual dysfunction and can cause significant distress or interpersonal difficulties for the individual affected.
Definition and Diagnosis[edit]
- HSDD is defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulties. Furthermore, the condition cannot be better explained by a non-sexual mental disorder, a consequence of severe relationship distress or other significant stressors, or attributable to the effects of a substance/medication or another medical condition[1].
- Diagnosis is typically made by a healthcare professional after a thorough medical and psychological examination, along with detailed inquiries about the individual's sexual and psychosocial history.
Causes and Risk Factors[edit]
- There are various potential causes and risk factors for HSDD, including both physical and psychological issues:
- Medical conditions such as diabetes, heart disease, or hormonal imbalances can impact sexual desire.
- Certain medications, including some antidepressants and contraceptives, can also decrease sexual desire.
- Psychological issues such as depression, anxiety, or past sexual trauma can contribute to HSDD.
- Relationship issues such as lack of emotional intimacy or unresolved conflict can also be associated with diminished sexual desire[2].
Treatment
- The treatment for HSDD typically involves a combination of medical treatment and psychotherapy:
- Medical treatment may include hormone therapy or FDA-approved medications like flibanserin for premenopausal women.
- Psychotherapy, such as cognitive-behavioral therapy (CBT), can be helpful in addressing underlying psychological issues or improving sexual communication with the partner[3]
Epidemiology[edit]
HSDD is a relatively common condition, with studies suggesting that it affects approximately 10% of adult women and is less prevalent among men. The prevalence increases with age and other risk factors[4].
Impact on Quality of Life[edit]
HSDD can have a significant impact on an individual's quality of life, affecting self-esteem, body image, and intimate relationships. The distress caused by this condition extends beyond the sexual realm, influencing overall mental health and well-being[5].
See also[edit]
- Sexual dysfunction
- Flibanserin
- Cognitive behavioral therapy
- Diagnostic and Statistical Manual of Mental Disorders
References[edit]
<references>
- |American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: Author.
- |Basson, R. (2010). Women's sexual function and dysfunction: current uncertainties, future directions. International Journal of Impotence Research, 22(5), 266–275.
- |Clayton, A.H., Goldfischer, E.R., Goldstein, I., Derogatis, L., Lewis-D'Agostino, D.J., & Pyke, R. (2013). Validation of the Decreased Sexual Desire Screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). The Journal of Sexual Medicine, 6(3), 730–738.
- |Shifren, J.L., Monz, B.U., Russo, P.A., Segreti, A., & Johannes, C.B. (2008). Sexual problems and distress in United States women: prevalence and correlates. Obstetrics & Gynecology, 112(5), 970–978.
- |Derogatis, L., Clayton, A., Lewis-D’Agostino, D., Wunderlich, G., & Fu, Y. (2008). Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with hypoactive sexual desire disorder. The Journal of Sexual Medicine, 5(2), 357–364.
</references>
